Antimicrobial drug use in hospitalised paediatric patients: A cross-national comparison between Germany and Croatia

Pharmacoepidemiology and Drug Safety

Volumn 14, Issue 10, 2005, Pages 735-739

  Ufer, Mike ^a,b   Radosevic N ^c   Vogt, A ^d   Palcevski G ^c   Francetic I ^e   Reinalter, S C ^d   Seyberth, H W ^d   Vlahovic Palcevski V ^a,c  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

^c KBC RIJEKA   (Croatia)

^d UNIVERSITY HOSPITAL MARBURG   (Germany)

^e KBC Zagreb   (Croatia)

Author keywords

Antimocrobial; Children; Drug utilisation; Inpatient; Paediatric

Indexed keywords

AMOXICILLIN; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIINFECTIVE AGENT; AZITHROMYCIN; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEFUROXIME; CEFUROXIME AXETIL; GENTAMICIN; PENICILLIN G;

ADOLESCENT; ADULT; AGE DISTRIBUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROATIA; DRUG INDICATION; DRUG MONITORING; DRUG USE; FEMALE; GEOGRAPHIC DISTRIBUTION; GERMANY; GROUPS BY AGE; HOSPITAL PATIENT; HUMAN; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; PNEUMONIA; POPULATION DISTRIBUTION; PRIORITY JOURNAL; PROSPECTIVE STUDY; RESPIRATORY TRACT INFECTION; SEX DIFFERENCE; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

ADOLESCENT; AGE FACTORS; ANTI-BACTERIAL AGENTS; BACTERIAL INFECTIONS; BENCHMARKING; CHILD; CHILD, HOSPITALIZED; CROATIA; DRUG RESISTANCE, BACTERIAL; DRUG UTILIZATION; FEMALE; GERMANY; HOSPITALS, UNIVERSITY; HUMANS; INFANT; LENGTH OF STAY; MALE; PROSPECTIVE STUDIES;

EID: 27144462033     PISSN: 10538569     EISSN: None     Source Type: Journal    
DOI: 10.1002/pds.1108     Document Type: Article

References (20)

1. World Health Organization. Monitoring and management of bacterial resistance to antimicrobial agents: a World Health Organization symposium. Geneva, Switzerland, 29 Novemher-2 December, 1995. Clin Infect Dis 1997; 24: S1-S176.
2. Johansen HL, Kampmann JM, Ingvardsen BK. Use of antibiotics among Danish children in 1998: consumption on a national basis. Ugeskr Laeger 2000; 162: 2028-2031.
3. Schirm E, van den Berg P, Gebben H, Sauer P, De Jong-van den Berg L. Drug use of children in the community assessed through pharmacy dispensing data. Br J Clin Pharmacol 2000; 50: 473-478.
4. Schindler C, Krappweis J, Morgenstern I, Kirch W. Prescriptions of systemic antibiotics for children in Germany aged between 0 and 6 years. Pharmacoepidemiol Drug Saf 2003; 12: 113-120.
5. Resi D, Milandri M, Moro ML. Antibiotic prescriptions in children. J Antimicrob Chemother 2003; 52: 282-286.
6. van Houten MA, Luinge K, Laseur M, Kimpen JL. Antibiotic utilisation for hospitalised paediatric patients. Int J Antimicrob Agents 1998; 10: 161-164.
7. Wise R, Hart T, Cars O, et al. Antimicrobial resistance is a major threat to public health. Br Med J 1998; 317: 609-610.
8. Fijn R, Chow MC, Schuur PM, De Jong-Van den Berg LT, Brouwers JR. Multicentre evaluation of prescribing concurrence with anti-infective guidelines: epidemiological assessment of indicators. Pharmacoepidemiol Drug Safe 2002; 11: 361-372.
9. Ekins-Daukes S, McLay JS, Taylor MW, Simpson CR, Helms PJ. Antibiotic prescribing for children: too much and too little? Retrospective observational study in primary care. Br J Clin Pharmacol 2003; 56: 92-95.
10. MacDonald TM, Collins D, McGilchrist MM, et al. The utilisation and economic evaluation of antibiotics prescribed in primary care. J Antimicrob Chemother 1995; 35: 191-204.
11. Shlaes DM, Gerding DN, John JF, Jr., et al. Society for Healthcare Epidemiology of America and Infectious Diseases Society of America Joint Committee on the Prevention of Antimicrobial Resistance: guidelines for the prevention of antimicrobial resistance in hospitals. Clin Infect Dis 1997; 25: 584-599.
12. Vlahovic-Palcevski V, Morovic M, Palcevski G. Antibiotic utilization at the university hospital after introducing an antibiotic policy. Eur J Clin Pharmacol 2000; 56: 97-101.
13. Molstad S, Lundborg CS, Karlsson AK, Cars G. Antibiotic prescription rates vary markedly between 13 European countries. Scand J Infect Dis 2002; 34: 366-371.
14. Cars O, Molstad S, Melander A. Variation in antibiotic use in the European Union. Lancet 2001; 357: 1851-1853.
15. Sanz E, Hernandez MA, Ratchina S, et al. Drug utilisation in outpatient children: a comparison among Tenerife, Valencia, and Barcelona (Spain), Toulouse (France), Sofia (Bulgaria), Bratislava (Slovakia) and Smolensk (Russia). Eur J Clin Pharmacol 2004; 60: 127-134. Epub 2004 Mar 12.
16. Palcevski G, Ahel V, Vlahovic-Palcevski V, Ratchina S, Rosovic-Bazijanac V, Averchenkova L. Antibiotic use profile at paediatric clinics in two transitional countries. Pharmacoepidemiol Drug Safe 2004; 13: 181-185.
17. World Health Organization Collaborating Centre for Drug Statistics Methodology. ATC index with DDDs Oslo. 2004.
18. Palcevski G. Monitoring and evaluation of the quality of drug use in children (Pracenje potrošnje i procjena kvalitete uporabe lijekova u djecjoj dobi). Doctoral thesis, Universiy of Rijeka Medical School, Rijeka, Croatia 2004.
19. Chambers HF. Beta-lactam antibiotics and other inhibitors of cell wall synthesis. In Basic and Clinical Pharmacology (9th edn), Katzung BG (ed.). McGraw-Hill: New York, 2004: 734-753.
20. World Health Organization. WHO Model Prescribing Information: Drugs Used in Bacterial Infections (Geneva), 2001.